A 24-year-old male reported a 7-month hairline recovery using 0.5mg of dutasteride daily with no side effects. Another user suggested adding minoxidil to the treatment.
PP405 is discussed as a potential alternative to finasteride, but its effectiveness and market availability are uncertain. Users share experiences with finasteride, minoxidil, and topical treatments, noting side effects and application techniques.
Scientists at UCLA have developed a promising treatment for male pattern baldness using a molecule called PP405, which can potentially stimulate dormant hair follicles. Initial trials showed significant results within a week, but larger clinical trials are needed to confirm its efficacy and safety.
The conversation is about the use of peptide therapies for hair loss, specifically GHK-CU, ZN-Thymulin, and PTD-DBM. The user is seeking feedback on the effectiveness of these treatments from those who have tried them.
The user experienced significant hair regrowth using dutasteride (0.5 mg three times a week) and RU58841 (5% once a day), with no side effects reported from RU58841. They are considering increasing the RU58841 dose or adding minoxidil for further improvement.
An 18-year-old is using a high-dose treatment for hair loss, including 2.5 mg dutasteride, topical minoxidil, and injectable GHK-Cu, despite minimal hair loss. Many users suggest reducing the dutasteride dose due to potential side effects and recommend starting with finasteride instead.
A 38-year-old considering switching from finasteride and minoxidil to dutasteride for hair maintenance, noting past success with finasteride but recent hair shedding. Users shared experiences, with some recommending dutasteride for better regrowth, while others noted potential shedding during the transition.
The user switched from Finasteride to Dutasteride 0.5mg daily for six months, experienced significant shedding, and noticed improvement after six months. They had a hair transplant last year and reported minor side effects, including a reduced sex drive.
A 19-20-year-old has been using 0.5 mg of dutasteride daily for a year to combat hair loss, avoiding minoxidil due to side effects. They plan to continue this regimen and consider a future hair transplant, experiencing no significant side effects from dutasteride.
A user is discussing their experience with finasteride for diffuse thinning without a receding hairline, noting a massive shedding phase in the fourth month that is now slowing down. Other replies are off-topic and not relevant to the treatment discussion.
In Turkey, finasteride and dutasteride can often be purchased without a prescription, despite some doctors recommending other treatments like PRP and exosome therapy. Users suggest trying different pharmacies to obtain these medications directly.
The user shared their one-year progress using oral Dutasteride and Minoxidil, reporting fuller and thicker hair without side effects. They noted no significant hairline gains but were satisfied with the overall results.
The user has high DHT levels despite using dutasteride, which may not be effective due to potential damage or spoilage. They are considering a hair transplant if DHT levels don't decrease after two years.
A 33-year-old user is seeking advice on adjusting their hair loss treatment, which includes daily finasteride, oral minoxidil, and various supplements. They are considering switching to alternate-day dosing of finasteride or dutasteride and are concerned about potential shedding and effectiveness.
Topical dutasteride 0.05% is reported to outperform oral finasteride with minimal side effects, but concerns about study bias exist due to company funding. Some users report mixed results with topical dutasteride, noting issues with skin penetration and systemic absorption.
Dutasteride is more effective than finasteride for increasing hair count, but finasteride is considered safer for long-term use unless hair loss is very aggressive. Starting with finasteride is recommended due to its effectiveness and safety profile.
PP405 is a promising molecule that may reactivate dormant hair follicles, potentially offering a new treatment for hair loss. It is in phase 2 trials, with possible availability between 2027 and 2030.
People are hopeful about future hair loss treatments like PP405, GT20029, and VDPHL01, while some are currently using finasteride and minoxidil. There is skepticism about the effectiveness of new treatments, and some advise against hair transplants until more promising drugs are available.
PP405 is seen as a potential breakthrough for converting vellus hairs to terminal hairs, with users expressing both hope and skepticism. It is compared to treatments like minoxidil and finasteride, with discussions on side effects and marketing concerns.
The user experienced significant hair growth using 0.5 mg Dutasteride and 5 mg oral Minoxidil over 10 weeks, with initial shedding but no side effects. The treatment was surprisingly affordable at $7 for a 3-month supply.
Dutasteride is often taken daily despite its long half-life because consistent dosing maintains optimal serum levels for effective DHT suppression. Some users report success with less frequent dosing, such as three times a week, but effectiveness can vary based on individual response and professional advice.
A 20-year-old has been using 1mg of dutasteride daily, caffeine shampoo, Nizoral shampoo 2-4 times a week, and pumpkin seed pills for hair growth, noticing regrowth since October. Initial shedding occurred, but improvements are felt, especially at the back of the hair.
Switching from daily 0.5mg dutasteride to three times a week may reduce side effects without worsening hair loss. Bloodwork showed no abnormalities, supporting the change.
The user plans to switch from finasteride to dutasteride for hair loss and is treating seborrheic dermatitis with Nizoral and Stanhome Balance shampoos. They are considering trying Vichy Psolution shampoo and Ciclopirox, and are dealing with challenges due to Vietnam's humidity.
A haircut and styling with Crew Whip Paste and hairspray improved the appearance of thinning hair. The user switched from finasteride to dutasteride, experiencing shedding but achieving better styling results.
The conversation discusses hair loss treatments, including finasteride, topical and oral minoxidil, and the potential use of dutasteride. The user shares progress and seeks advice on whether to start dutasteride, noting positive results with current treatments but concerns about long-term effects.
A user shared their one-year progress on dutasteride, noting fuller hair but persistent thinning at the crown. They sought advice on whether to resume minoxidil and in which form, while others inquired about their choice of dutasteride and its effects.
The conversation discusses hair shedding while using 0.5 mg daily Dutasteride for nine months, with some users suggesting that shedding is normal and may stabilize over time. Others share experiences of switching from Dutasteride to Finasteride due to prolonged hair loss.
Dutasteride and finasteride mesotherapy may have fewer side effects like erectile dysfunction and libido loss compared to oral treatments, but it's less effective and more costly. Few people discuss it, and experiences with mesotherapy are limited.
A new treatment using dermal sheath cup cells may regrow hair and could require repeat treatments every 8 years. Users discuss ongoing trials and plan to use finasteride and minoxidil until the treatment is available.